I am a medical oncologist and drug developer dedicated to translating innovative science into breakthrough therapies for patients with cancer.
As Executive Chair of Head & Neck Research at Sarah Cannon Research Institute, I am recognized as a key opinion leader in head & neck oncology, shaping the design and execution of early clinical development programs in this space.
Beyond head & neck, my expertise extends across all solid tumors as a first-in-human and early-phase trialist. At the Lake Nona Drug Development Unit, part of Florida Cancer Specialists & Sarah Cannon Research Institute, I am part of one of the largest early-phase oncology programs in the U.S., focusing on novel agents in immuno-oncology, ADCs, and targeted therapies.
Over the past decade, I have collaborated with pharmaceutical and biotech partners worldwide to bring first-in-class and first-in-human compounds from concept to clinic.
